Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Front Pharmacol. 2021 Oct 20:12:792330. doi: 10.3389/fphar.2021.792330. eCollection 2021.

Tianyu Zhai^{1

2

3}, Xiaoyu Zhang¹, Zhenyu Hei¹, Longyang Jin⁴, Chao Han⁵, Audrey Tsznam Ko⁶, Xiaofeng Yu⁷, Jiandong Wang^{1

2

3}

¹ Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Shanghai Research Center of Biliary Tract Disease, Shanghai, China.
³ Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
⁴ Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
⁵ Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁶ Faculty of Medicine, Imperial College London, London, United Kingdom.
⁷ Department of General Surgery, People's Hospital of Gaoxin District, Suzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.628621.].

Keywords: PI3K/Akt pathway; apoptosis; gallbladder cancer; isorhamnetin; tumor progression.